21:19:23 EST Mon 04 Dec 2023
Enter Symbol
or Name
USA
CA



T:ATE - ANTIBE THERAPEUTICS INC. J - http://www.antibethera.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ATE - T  1.00.74·0.750.50.75+0.022.758.541450.73  0.75  0.731.23  0.4115:57:43Nov 1315 min RT 2¢
TSX - T1.00.74·0.750.50.74+0.011.420.514160.73  0.75  0.731.23  0.4115:05:4115 min
NEO ATS - U 0.734.0320.75  0.75  0.7313:42:0415 min
Alpha - A 0.735.0410.73  0.73  0.7313:27:1015 min
Omega - O 0.75+0.022.75.5430.75  0.75  0.7515:57:4315 min
CX2 - H 0.7318.01350.75  0.75  0.7313:40:3215 min
CXD - D 0.731.117    Nov 0915 min
TriAct - M 0.734.4311    Sep 09-2015 min

Recent Trades - Last 10 of 45
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:57:43O0.750.022,0001 Anonymous1 AnonymousK
15:05:41D0.740.012007 TD Sec7 TD SecE
15:05:41T0.740.015007 TD Sec7 TD SecK
14:51:09M0.750.02214 Virtu ITG14 Virtu ITG
14:29:40T0.740.011,0007 TD Sec85 ScotiaK
14:25:30D0.740.011007 TD Sec28 CIE
14:20:21T0.740.016,0007 TD Sec1 AnonymousK
14:20:02T0.740.015007 TD Sec39 Merrill LynchK
14:20:02T0.740.011,0007 TD Sec7 TD SecK
14:20:02T0.740.015007 TD Sec7 TD SecK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2023-11-13 11:37C:ATE0.93News ReleaseAntibe spends $3.5M on R&D in fiscal Q2 2024
2023-11-13 06:36C:ATE0.93SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-13 06:34C:ATE0.93SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-09 10:21C:ATE1.18News ReleaseAntibe talks PK results of otenaproxesul study